Holen Sie sich die Stockscreener-App
6.75
5.73%
-0.41
Handel nachbörslich:
6.75
Schlusskurs vom Vortag:
$7.16
Offen:
$7.29
24-Stunden-Volumen:
41,658
Relative Volume:
1.26
Marktkapitalisierung:
$49.09M
Einnahmen:
$71,000
Nettoeinkommen (Verlust:
$-2.47M
KGV:
-0.2051
EPS:
-32.9143
Netto-Cashflow:
$-5.24M
1W Leistung:
-16.97%
1M Leistung:
-26.95%
6M Leistung:
-35.71%
1J Leistung:
-67.00%
1-Tages-Spanne:
$6.75
$7.31
1-Wochen-Bereich:
$6.75
$8.20
52-Wochen-Spanne:
$6.00
$28.44
Pavmed Inc Stock (PAVM) Company Profile
Firmenname
Pavmed Inc
Sektor
Branche
Telefon
(212) 949-4319
Adresse
360 MADISON AVENUE, NEW YORK, NY
Compare PAVM vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PAVM
Pavmed Inc
|
6.75 | 52.07M | 71,000 | -2.47M | -5.24M | -32.91 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Pavmed Inc Stock (PAVM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-03-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-11-05 | Eingeleitet | Ascendiant Capital Markets | Buy |
| 2018-06-28 | Eingeleitet | Maxim Group | Buy |
Pavmed Inc Aktie (PAVM) Neueste Nachrichten
PAVMED (PAVM) holder group reports 709,069 shares, 9.99% stake - Stock Titan
Will PAVmed Inc. (PAVM) report negative earnings next week? What you should know - MSN
MSN Money - MSN
Will PAVmed Inc. (PAVM) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance
PAVmed (PAVM) Stock Price, News & Analysis - MarketBeat
Q1 2025 PAVmed Inc Earnings Call Transcript - GuruFocus
Q3 2025 PAVmed Inc Earnings Call Transcript - GuruFocus
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
PAVmed Inc (FRA:1P5) Stock Earnings Transcripts - GuruFocus
PAVmed Inc (FRA:1P5) Stock Price & 30 Year Financial Data - GuruFocus
PAVmed Inc (FRA:1P5) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
PAVmed (PAVM) 2026 proxy: ESPP share increase, director elections and auditor vote - Stock Titan
PAVmed will outline Q1 results and strategy in a May 15 webcast - Stock Titan
PAVmed to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 15, 2026 - ChartMill
[ARS] PAVmed Inc. SEC Filing - Stock Titan
Lucid Diagnostics (NASDAQ: LUCD) seeks big share increase in 2026 proxy - Stock Titan
Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026 - BioSpace
Lucid Diagnostics to Hold First Quarter 2026 Business Update Con - GuruFocus
[EFFECT] PAVmed Inc. SEC Filing - Stock Titan
Lucid Diagnostics will detail Q1 results and strategy on May 14 - Stock Titan
PAVmed Inc. (NASDAQ: PAVM) registers 9.23M shares from Series D conversion - Stock Titan
PAVmed (PAVM) price target decreased by 84.60% to 41.31 - MSN
PAVmed Inc (STU:1P5) Stock PDF (Updated: 2026/04/28) - GuruFocus
Debt to equity ratio of PAVmed, Inc. – FWB:1P5 - TradingView
Pretax income of PAVmed, Inc. – FWB:1P5 - TradingView
Free cash flow of PAVmed, Inc. – FWB:1P5 - TradingView
Return on invested capital % of PAVmed, Inc. – FWB:1P5 - TradingView
Taxes of PAVmed, Inc. – FWB:1P5 - TradingView
Debt to assets ratio of PAVmed, Inc. – FWB:1P5 - TradingView
Total equity of PAVmed, Inc. – FWB:1P5 - TradingView
PAVmed (PAVM) upgraded to buy: Here's what you should know - MSN
PAVmed Q2 2025 Earnings Preview - MSN
Why The PAVmed (PAVM) Story Is Shifting After A Major Valuation Reset - Yahoo Finance
Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock - marketscreener.com
PAVmed (PAVM) price target increased by 2,900.00% to 321.30 - MSN
Lucid Diagnostics Raises Capital Through Direct Share Offering - The Globe and Mail
Lucid Diagnostics closes $18M stock offering at $1 per share - Investing.com Australia
Latest PAVM NewsPAVmed Collaborates with Canon on DisappEAR... - Stock Titan
Lucid Diagnostics (NASDAQ: LUCD) closes $18M underwritten stock sale - Stock Titan
Lucid Diagnostics closes $18M stock offering at $1 per share By Investing.com - Investing.com India
Lucid Diagnostics prices $18M stock offering at $1 per share - Investing.com India
Lucid Diagnostics Prices $18 Million Public Equity Offering - TipRanks
Lucid Diagnostics (Nasdaq: LUCD) prices $18M underwritten stock sale - Stock Titan
Lucid Diagnostics prices $18M stock offering at $1 per share By Investing.com - Investing.com South Africa
Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock - Financial Times
PAVmed Inc. (PAVM) posts narrow Q4 2025 EPS miss, shares edge higher in muted investor trading.Community Exit Signals - Cổng thông tin điện tử tỉnh Tây Ninh
Finanzdaten der Pavmed Inc-Aktie (PAVM)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):